Abstract
Background and objectives: Lutein and zeaxanthin (L+Z) are carotenoids highly concentrated in the macula to maintain macular pigment optical density (MPOD) throughout the lifespan. Studies have shown that an intake of 6–20 mg or higher of L+Z would be beneficial for visual function and cognition. The human body cannot synthesize L+Z and must obtain them from other sources. Objective: To determine the nutrient intake status of L+Z in US children (6–18 years) and adults (19–64 years), and how dietary supplements contribute to the total intake level of L+Z. Methods: Data from NHANES 2003-08 cycles were used to estimate the mean intakes of L+Z from food and food + supplements (F+S). Children and adults were analyzed according to age groups: 6–8 years, 9–13 years, and 14–18 years for children, and 19–30 years, 31–50 years, and 51–64 years for adults. Results: In adults (n = 8252), the mean (SE) dietary intake of L+Z from food was 1.322 mg (0.040), which was similar to the intake from F+S: 1.396 mg (0.041). For both adult men and women, the mean intake increased by age, with the lowest intake of 1.047 mg (0.039) from food in adult women aged 19–30 years, and the highest intake of 1.700 mg (0.069) from F+S in adult men aged 51–64 years. In children (n = 7429), the mean (SE) intake of L+Z was 0.743 mg (0.026) from food, and 0.748 mg (0.026) from F+S. The intake levels among all age groups in children were similar, with the lowest intake of 0.686 mg (0.028) from food in girls 14–18 years, and the highest intake of 0.801 mg (0.038) from F+S in boys 9–13 years. Discussion: We found that the dietary intake levels of L+Z in US were much lower than levels recognized to support brain and eye health. Supplementation only marginally increased the total intake, which may indicate a lack of consumer awareness. Efforts are needed to raise public awareness of the health benefits of L+Z and encourage more consumption of L+Z-containing food (dark leafy greens and yellow or orange fruits/vegetables) and supplements by establishing dietary guidance for L+Z. This research was funded by Pharmavite LLC.
Keywords:
lutein; zeaxanthin; NHANES; nutritional status; dietary intake; supplement; children; adults; visual; cognition Author Contributions
Conceptualization, S.H.M., Q.Y. and R.W.G.; methodology and analysis, Q.Y. and P.P.D.; data interpretation, S.H.M., Q.Y. and R.W.G.; writing, review, and editing, S.H.M., Q.Y., P.P.D. and R.W.G. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by Pharmavite LLC.
Institutional Review Board Statement
This study is an analysis of the publicly available NHANES data. All NHANES protocols were approved by the NCHS Research Ethics Review Board and underwent annual review. Use of the public use data sets requires neither additional institutional review board review nor an exempt determination.
Informed Consent Statement
Informed consent was obtained from NHANES participants by NCHS.
Data Availability Statement
The datasets analyzed during the current study are available in the NHANES repository at the following links: NHANES 2003–2004: https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2003; NHANES 2005–2006: https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2005; NHANES 2007–2008: https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2007.
Conflicts of Interest
Pharmavite, LLC sponsored the study. S.H.M. Q.Y., P.P.D. and R.W.G. are employees of Pharmavite, LLC.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).